Haploidentical Stem Cell Transplant With Prophylactic With Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL

Conditions:   Multiple Myeloma;   CLL;   Chronic Lymphocytic Leukemia;   Lymphoma Interventions:   Radiation: Total Body Irradiation;   Procedure: Haploidentical Stem Cell Transplantation;   Biological: CD56-Enriched Donor Lymphocyte Infusion;   Drug: Bendamustine;   Drug: Fludarabine;   Drug: Rituximab Sponsors:   Noah Merin;   Miltenyi Biotec GmbH;   TEVA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials